Cardiovascular Risks Resurface Old Concerns About Sulfonylureas for T2D

By News Health
1 day Ago

(MedPage Today) — Sulfonylureas were flagged for excess cardiovascular risk when used for additional glucose lowering in type 2 diabetes (T2D) in an observational comparative effectiveness study.
As second-line therapies atop metformin, individual…

Source link : https://www.medpagetoday.com/endocrinology/diabetes/116664

Author :

Publish date : 2025-07-24 21:19:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Solar drone with wingspan wider than jumbo jet could fly for months

Study Touts Benefit of Mini Nonhormonal IUD -- But It's Not Sold in the U.S.

Negative social ties, like frenemies, could be ageing you

Could Direct Primary Care’s Popularity Be on the Rise?

Will 'Safe Staffing Committee' Laws Help Reduce ED Wait Times?

Ultraprocessed Foods Tied to Worse Parkinson's Outcomes